Medical Care
Global Biosimilar Testing Service Market Research Report 2025
- Jul 08, 25
- ID: 347974
- Pages: 87
- Figures: 84
- Views: 1
The global market for Biosimilar Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biosimilar are the biological based products used for various use in healthcare industry. Biosimilar products are very helpful to the patients and also offer therapeutic options. Biosimilar have a unique properties, which is used to study the biological functions and structures complexity of the sample.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biosimilar Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Testing Service.
The Biosimilar Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories International
Merck
PPD
LAB Holdings
Eurofins Scientific
Intertek
SGS
Profacgen
Antibody Analytics
Kymos Pharma Services
Medicilon
Pacific BioLabs
Sartorius
Segment by Type
Pharmacokinetic Assay
Tiered Immunogenicity Testing
Others
Segment by Application
Hospitals
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biosimilar are the biological based products used for various use in healthcare industry. Biosimilar products are very helpful to the patients and also offer therapeutic options. Biosimilar have a unique properties, which is used to study the biological functions and structures complexity of the sample.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biosimilar Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Testing Service.
The Biosimilar Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories International
Merck
PPD
LAB Holdings
Eurofins Scientific
Intertek
SGS
Profacgen
Antibody Analytics
Kymos Pharma Services
Medicilon
Pacific BioLabs
Sartorius
Segment by Type
Pharmacokinetic Assay
Tiered Immunogenicity Testing
Others
Segment by Application
Hospitals
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmacokinetic Assay
1.2.3 Tiered Immunogenicity Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosimilar Testing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing Service Market Perspective (2020-2031)
2.2 Global Biosimilar Testing Service Growth Trends by Region
2.2.1 Global Biosimilar Testing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biosimilar Testing Service Historic Market Size by Region (2020-2025)
2.2.3 Biosimilar Testing Service Forecasted Market Size by Region (2026-2031)
2.3 Biosimilar Testing Service Market Dynamics
2.3.1 Biosimilar Testing Service Industry Trends
2.3.2 Biosimilar Testing Service Market Drivers
2.3.3 Biosimilar Testing Service Market Challenges
2.3.4 Biosimilar Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing Service Players by Revenue
3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2020-2025)
3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2020-2025)
3.2 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biosimilar Testing Service Revenue
3.4 Global Biosimilar Testing Service Market Concentration Ratio
3.4.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2024
3.5 Global Key Players of Biosimilar Testing Service Head office and Area Served
3.6 Global Key Players of Biosimilar Testing Service, Product and Application
3.7 Global Key Players of Biosimilar Testing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing Service Breakdown Data by Type
4.1 Global Biosimilar Testing Service Historic Market Size by Type (2020-2025)
4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2026-2031)
5 Biosimilar Testing Service Breakdown Data by Application
5.1 Global Biosimilar Testing Service Historic Market Size by Application (2020-2025)
5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biosimilar Testing Service Market Size (2020-2031)
6.2 North America Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biosimilar Testing Service Market Size by Country (2020-2025)
6.4 North America Biosimilar Testing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Testing Service Market Size (2020-2031)
7.2 Europe Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biosimilar Testing Service Market Size by Country (2020-2025)
7.4 Europe Biosimilar Testing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing Service Market Size (2020-2031)
8.2 Asia-Pacific Biosimilar Testing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biosimilar Testing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Biosimilar Testing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Testing Service Market Size (2020-2031)
9.2 Latin America Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biosimilar Testing Service Market Size by Country (2020-2025)
9.4 Latin America Biosimilar Testing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing Service Market Size (2020-2031)
10.2 Middle East & Africa Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biosimilar Testing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Biosimilar Testing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories International
11.1.1 Charles River Laboratories International Company Details
11.1.2 Charles River Laboratories International Business Overview
11.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction
11.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2020-2025)
11.1.5 Charles River Laboratories International Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Biosimilar Testing Service Introduction
11.2.4 Merck Revenue in Biosimilar Testing Service Business (2020-2025)
11.2.5 Merck Recent Development
11.3 PPD
11.3.1 PPD Company Details
11.3.2 PPD Business Overview
11.3.3 PPD Biosimilar Testing Service Introduction
11.3.4 PPD Revenue in Biosimilar Testing Service Business (2020-2025)
11.3.5 PPD Recent Development
11.4 LAB Holdings
11.4.1 LAB Holdings Company Details
11.4.2 LAB Holdings Business Overview
11.4.3 LAB Holdings Biosimilar Testing Service Introduction
11.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2020-2025)
11.4.5 LAB Holdings Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Biosimilar Testing Service Introduction
11.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Intertek
11.6.1 Intertek Company Details
11.6.2 Intertek Business Overview
11.6.3 Intertek Biosimilar Testing Service Introduction
11.6.4 Intertek Revenue in Biosimilar Testing Service Business (2020-2025)
11.6.5 Intertek Recent Development
11.7 SGS
11.7.1 SGS Company Details
11.7.2 SGS Business Overview
11.7.3 SGS Biosimilar Testing Service Introduction
11.7.4 SGS Revenue in Biosimilar Testing Service Business (2020-2025)
11.7.5 SGS Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Details
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Biosimilar Testing Service Introduction
11.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2020-2025)
11.8.5 Profacgen Recent Development
11.9 Antibody Analytics
11.9.1 Antibody Analytics Company Details
11.9.2 Antibody Analytics Business Overview
11.9.3 Antibody Analytics Biosimilar Testing Service Introduction
11.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2020-2025)
11.9.5 Antibody Analytics Recent Development
11.10 Kymos Pharma Services
11.10.1 Kymos Pharma Services Company Details
11.10.2 Kymos Pharma Services Business Overview
11.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction
11.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2020-2025)
11.10.5 Kymos Pharma Services Recent Development
11.11 Medicilon
11.11.1 Medicilon Company Details
11.11.2 Medicilon Business Overview
11.11.3 Medicilon Biosimilar Testing Service Introduction
11.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2020-2025)
11.11.5 Medicilon Recent Development
11.12 Pacific BioLabs
11.12.1 Pacific BioLabs Company Details
11.12.2 Pacific BioLabs Business Overview
11.12.3 Pacific BioLabs Biosimilar Testing Service Introduction
11.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2020-2025)
11.12.5 Pacific BioLabs Recent Development
11.13 Sartorius
11.13.1 Sartorius Company Details
11.13.2 Sartorius Business Overview
11.13.3 Sartorius Biosimilar Testing Service Introduction
11.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2020-2025)
11.13.5 Sartorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmacokinetic Assay
1.2.3 Tiered Immunogenicity Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosimilar Testing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing Service Market Perspective (2020-2031)
2.2 Global Biosimilar Testing Service Growth Trends by Region
2.2.1 Global Biosimilar Testing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biosimilar Testing Service Historic Market Size by Region (2020-2025)
2.2.3 Biosimilar Testing Service Forecasted Market Size by Region (2026-2031)
2.3 Biosimilar Testing Service Market Dynamics
2.3.1 Biosimilar Testing Service Industry Trends
2.3.2 Biosimilar Testing Service Market Drivers
2.3.3 Biosimilar Testing Service Market Challenges
2.3.4 Biosimilar Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing Service Players by Revenue
3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2020-2025)
3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2020-2025)
3.2 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biosimilar Testing Service Revenue
3.4 Global Biosimilar Testing Service Market Concentration Ratio
3.4.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2024
3.5 Global Key Players of Biosimilar Testing Service Head office and Area Served
3.6 Global Key Players of Biosimilar Testing Service, Product and Application
3.7 Global Key Players of Biosimilar Testing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing Service Breakdown Data by Type
4.1 Global Biosimilar Testing Service Historic Market Size by Type (2020-2025)
4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2026-2031)
5 Biosimilar Testing Service Breakdown Data by Application
5.1 Global Biosimilar Testing Service Historic Market Size by Application (2020-2025)
5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biosimilar Testing Service Market Size (2020-2031)
6.2 North America Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biosimilar Testing Service Market Size by Country (2020-2025)
6.4 North America Biosimilar Testing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Testing Service Market Size (2020-2031)
7.2 Europe Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biosimilar Testing Service Market Size by Country (2020-2025)
7.4 Europe Biosimilar Testing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing Service Market Size (2020-2031)
8.2 Asia-Pacific Biosimilar Testing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biosimilar Testing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Biosimilar Testing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Testing Service Market Size (2020-2031)
9.2 Latin America Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biosimilar Testing Service Market Size by Country (2020-2025)
9.4 Latin America Biosimilar Testing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing Service Market Size (2020-2031)
10.2 Middle East & Africa Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biosimilar Testing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Biosimilar Testing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories International
11.1.1 Charles River Laboratories International Company Details
11.1.2 Charles River Laboratories International Business Overview
11.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction
11.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2020-2025)
11.1.5 Charles River Laboratories International Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Biosimilar Testing Service Introduction
11.2.4 Merck Revenue in Biosimilar Testing Service Business (2020-2025)
11.2.5 Merck Recent Development
11.3 PPD
11.3.1 PPD Company Details
11.3.2 PPD Business Overview
11.3.3 PPD Biosimilar Testing Service Introduction
11.3.4 PPD Revenue in Biosimilar Testing Service Business (2020-2025)
11.3.5 PPD Recent Development
11.4 LAB Holdings
11.4.1 LAB Holdings Company Details
11.4.2 LAB Holdings Business Overview
11.4.3 LAB Holdings Biosimilar Testing Service Introduction
11.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2020-2025)
11.4.5 LAB Holdings Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Biosimilar Testing Service Introduction
11.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Intertek
11.6.1 Intertek Company Details
11.6.2 Intertek Business Overview
11.6.3 Intertek Biosimilar Testing Service Introduction
11.6.4 Intertek Revenue in Biosimilar Testing Service Business (2020-2025)
11.6.5 Intertek Recent Development
11.7 SGS
11.7.1 SGS Company Details
11.7.2 SGS Business Overview
11.7.3 SGS Biosimilar Testing Service Introduction
11.7.4 SGS Revenue in Biosimilar Testing Service Business (2020-2025)
11.7.5 SGS Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Details
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Biosimilar Testing Service Introduction
11.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2020-2025)
11.8.5 Profacgen Recent Development
11.9 Antibody Analytics
11.9.1 Antibody Analytics Company Details
11.9.2 Antibody Analytics Business Overview
11.9.3 Antibody Analytics Biosimilar Testing Service Introduction
11.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2020-2025)
11.9.5 Antibody Analytics Recent Development
11.10 Kymos Pharma Services
11.10.1 Kymos Pharma Services Company Details
11.10.2 Kymos Pharma Services Business Overview
11.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction
11.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2020-2025)
11.10.5 Kymos Pharma Services Recent Development
11.11 Medicilon
11.11.1 Medicilon Company Details
11.11.2 Medicilon Business Overview
11.11.3 Medicilon Biosimilar Testing Service Introduction
11.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2020-2025)
11.11.5 Medicilon Recent Development
11.12 Pacific BioLabs
11.12.1 Pacific BioLabs Company Details
11.12.2 Pacific BioLabs Business Overview
11.12.3 Pacific BioLabs Biosimilar Testing Service Introduction
11.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2020-2025)
11.12.5 Pacific BioLabs Recent Development
11.13 Sartorius
11.13.1 Sartorius Company Details
11.13.2 Sartorius Business Overview
11.13.3 Sartorius Biosimilar Testing Service Introduction
11.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2020-2025)
11.13.5 Sartorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Testing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pharmacokinetic Assay
Table 3. Key Players of Tiered Immunogenicity Testing
Table 4. Key Players of Others
Table 5. Global Biosimilar Testing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biosimilar Testing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biosimilar Testing Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Biosimilar Testing Service Market Share by Region (2020-2025)
Table 9. Global Biosimilar Testing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Biosimilar Testing Service Market Share by Region (2026-2031)
Table 11. Biosimilar Testing Service Market Trends
Table 12. Biosimilar Testing Service Market Drivers
Table 13. Biosimilar Testing Service Market Challenges
Table 14. Biosimilar Testing Service Market Restraints
Table 15. Global Biosimilar Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Biosimilar Testing Service Market Share by Players (2020-2025)
Table 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2024)
Table 18. Ranking of Global Top Biosimilar Testing Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Biosimilar Testing Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Biosimilar Testing Service, Headquarters and Area Served
Table 21. Global Key Players of Biosimilar Testing Service, Product and Application
Table 22. Global Key Players of Biosimilar Testing Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosimilar Testing Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Biosimilar Testing Service Revenue Market Share by Type (2020-2025)
Table 26. Global Biosimilar Testing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Biosimilar Testing Service Revenue Market Share by Type (2026-2031)
Table 28. Global Biosimilar Testing Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Biosimilar Testing Service Revenue Market Share by Application (2020-2025)
Table 30. Global Biosimilar Testing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Biosimilar Testing Service Revenue Market Share by Application (2026-2031)
Table 32. North America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Biosimilar Testing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Biosimilar Testing Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Biosimilar Testing Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. Charles River Laboratories International Company Details
Table 48. Charles River Laboratories International Business Overview
Table 49. Charles River Laboratories International Biosimilar Testing Service Product
Table 50. Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 51. Charles River Laboratories International Recent Development
Table 52. Merck Company Details
Table 53. Merck Business Overview
Table 54. Merck Biosimilar Testing Service Product
Table 55. Merck Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 56. Merck Recent Development
Table 57. PPD Company Details
Table 58. PPD Business Overview
Table 59. PPD Biosimilar Testing Service Product
Table 60. PPD Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 61. PPD Recent Development
Table 62. LAB Holdings Company Details
Table 63. LAB Holdings Business Overview
Table 64. LAB Holdings Biosimilar Testing Service Product
Table 65. LAB Holdings Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 66. LAB Holdings Recent Development
Table 67. Eurofins Scientific Company Details
Table 68. Eurofins Scientific Business Overview
Table 69. Eurofins Scientific Biosimilar Testing Service Product
Table 70. Eurofins Scientific Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 71. Eurofins Scientific Recent Development
Table 72. Intertek Company Details
Table 73. Intertek Business Overview
Table 74. Intertek Biosimilar Testing Service Product
Table 75. Intertek Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 76. Intertek Recent Development
Table 77. SGS Company Details
Table 78. SGS Business Overview
Table 79. SGS Biosimilar Testing Service Product
Table 80. SGS Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 81. SGS Recent Development
Table 82. Profacgen Company Details
Table 83. Profacgen Business Overview
Table 84. Profacgen Biosimilar Testing Service Product
Table 85. Profacgen Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 86. Profacgen Recent Development
Table 87. Antibody Analytics Company Details
Table 88. Antibody Analytics Business Overview
Table 89. Antibody Analytics Biosimilar Testing Service Product
Table 90. Antibody Analytics Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 91. Antibody Analytics Recent Development
Table 92. Kymos Pharma Services Company Details
Table 93. Kymos Pharma Services Business Overview
Table 94. Kymos Pharma Services Biosimilar Testing Service Product
Table 95. Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 96. Kymos Pharma Services Recent Development
Table 97. Medicilon Company Details
Table 98. Medicilon Business Overview
Table 99. Medicilon Biosimilar Testing Service Product
Table 100. Medicilon Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 101. Medicilon Recent Development
Table 102. Pacific BioLabs Company Details
Table 103. Pacific BioLabs Business Overview
Table 104. Pacific BioLabs Biosimilar Testing Service Product
Table 105. Pacific BioLabs Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 106. Pacific BioLabs Recent Development
Table 107. Sartorius Company Details
Table 108. Sartorius Business Overview
Table 109. Sartorius Biosimilar Testing Service Product
Table 110. Sartorius Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 111. Sartorius Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Biosimilar Testing Service Picture
Figure 2. Global Biosimilar Testing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biosimilar Testing Service Market Share by Type: 2024 VS 2031
Figure 4. Pharmacokinetic Assay Features
Figure 5. Tiered Immunogenicity Testing Features
Figure 6. Others Features
Figure 7. Global Biosimilar Testing Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Biosimilar Testing Service Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Others Case Studies
Figure 12. Biosimilar Testing Service Report Years Considered
Figure 13. Global Biosimilar Testing Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biosimilar Testing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biosimilar Testing Service Market Share by Region: 2024 VS 2031
Figure 16. Global Biosimilar Testing Service Market Share by Players in 2024
Figure 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Biosimilar Testing Service Revenue in 2024
Figure 19. North America Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 21. United States Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 25. Germany Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biosimilar Testing Service Market Share by Region (2020-2031)
Figure 33. China Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 41. Mexico Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 45. Turkey Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Charles River Laboratories International Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 49. Merck Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 50. PPD Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 51. LAB Holdings Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 53. Intertek Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 54. SGS Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 55. Profacgen Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 56. Antibody Analytics Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 57. Kymos Pharma Services Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 58. Medicilon Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 59. Pacific BioLabs Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 60. Sartorius Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Biosimilar Testing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pharmacokinetic Assay
Table 3. Key Players of Tiered Immunogenicity Testing
Table 4. Key Players of Others
Table 5. Global Biosimilar Testing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biosimilar Testing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biosimilar Testing Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Biosimilar Testing Service Market Share by Region (2020-2025)
Table 9. Global Biosimilar Testing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Biosimilar Testing Service Market Share by Region (2026-2031)
Table 11. Biosimilar Testing Service Market Trends
Table 12. Biosimilar Testing Service Market Drivers
Table 13. Biosimilar Testing Service Market Challenges
Table 14. Biosimilar Testing Service Market Restraints
Table 15. Global Biosimilar Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Biosimilar Testing Service Market Share by Players (2020-2025)
Table 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2024)
Table 18. Ranking of Global Top Biosimilar Testing Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Biosimilar Testing Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Biosimilar Testing Service, Headquarters and Area Served
Table 21. Global Key Players of Biosimilar Testing Service, Product and Application
Table 22. Global Key Players of Biosimilar Testing Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosimilar Testing Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Biosimilar Testing Service Revenue Market Share by Type (2020-2025)
Table 26. Global Biosimilar Testing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Biosimilar Testing Service Revenue Market Share by Type (2026-2031)
Table 28. Global Biosimilar Testing Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Biosimilar Testing Service Revenue Market Share by Application (2020-2025)
Table 30. Global Biosimilar Testing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Biosimilar Testing Service Revenue Market Share by Application (2026-2031)
Table 32. North America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Biosimilar Testing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Biosimilar Testing Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Biosimilar Testing Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. Charles River Laboratories International Company Details
Table 48. Charles River Laboratories International Business Overview
Table 49. Charles River Laboratories International Biosimilar Testing Service Product
Table 50. Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 51. Charles River Laboratories International Recent Development
Table 52. Merck Company Details
Table 53. Merck Business Overview
Table 54. Merck Biosimilar Testing Service Product
Table 55. Merck Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 56. Merck Recent Development
Table 57. PPD Company Details
Table 58. PPD Business Overview
Table 59. PPD Biosimilar Testing Service Product
Table 60. PPD Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 61. PPD Recent Development
Table 62. LAB Holdings Company Details
Table 63. LAB Holdings Business Overview
Table 64. LAB Holdings Biosimilar Testing Service Product
Table 65. LAB Holdings Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 66. LAB Holdings Recent Development
Table 67. Eurofins Scientific Company Details
Table 68. Eurofins Scientific Business Overview
Table 69. Eurofins Scientific Biosimilar Testing Service Product
Table 70. Eurofins Scientific Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 71. Eurofins Scientific Recent Development
Table 72. Intertek Company Details
Table 73. Intertek Business Overview
Table 74. Intertek Biosimilar Testing Service Product
Table 75. Intertek Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 76. Intertek Recent Development
Table 77. SGS Company Details
Table 78. SGS Business Overview
Table 79. SGS Biosimilar Testing Service Product
Table 80. SGS Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 81. SGS Recent Development
Table 82. Profacgen Company Details
Table 83. Profacgen Business Overview
Table 84. Profacgen Biosimilar Testing Service Product
Table 85. Profacgen Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 86. Profacgen Recent Development
Table 87. Antibody Analytics Company Details
Table 88. Antibody Analytics Business Overview
Table 89. Antibody Analytics Biosimilar Testing Service Product
Table 90. Antibody Analytics Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 91. Antibody Analytics Recent Development
Table 92. Kymos Pharma Services Company Details
Table 93. Kymos Pharma Services Business Overview
Table 94. Kymos Pharma Services Biosimilar Testing Service Product
Table 95. Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 96. Kymos Pharma Services Recent Development
Table 97. Medicilon Company Details
Table 98. Medicilon Business Overview
Table 99. Medicilon Biosimilar Testing Service Product
Table 100. Medicilon Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 101. Medicilon Recent Development
Table 102. Pacific BioLabs Company Details
Table 103. Pacific BioLabs Business Overview
Table 104. Pacific BioLabs Biosimilar Testing Service Product
Table 105. Pacific BioLabs Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 106. Pacific BioLabs Recent Development
Table 107. Sartorius Company Details
Table 108. Sartorius Business Overview
Table 109. Sartorius Biosimilar Testing Service Product
Table 110. Sartorius Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)
Table 111. Sartorius Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Biosimilar Testing Service Picture
Figure 2. Global Biosimilar Testing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biosimilar Testing Service Market Share by Type: 2024 VS 2031
Figure 4. Pharmacokinetic Assay Features
Figure 5. Tiered Immunogenicity Testing Features
Figure 6. Others Features
Figure 7. Global Biosimilar Testing Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Biosimilar Testing Service Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Others Case Studies
Figure 12. Biosimilar Testing Service Report Years Considered
Figure 13. Global Biosimilar Testing Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biosimilar Testing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biosimilar Testing Service Market Share by Region: 2024 VS 2031
Figure 16. Global Biosimilar Testing Service Market Share by Players in 2024
Figure 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Biosimilar Testing Service Revenue in 2024
Figure 19. North America Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 21. United States Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 25. Germany Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biosimilar Testing Service Market Share by Region (2020-2031)
Figure 33. China Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 41. Mexico Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biosimilar Testing Service Market Share by Country (2020-2031)
Figure 45. Turkey Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Charles River Laboratories International Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 49. Merck Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 50. PPD Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 51. LAB Holdings Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 53. Intertek Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 54. SGS Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 55. Profacgen Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 56. Antibody Analytics Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 57. Kymos Pharma Services Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 58. Medicilon Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 59. Pacific BioLabs Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 60. Sartorius Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232